Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 108 of the 110 references it cites were found in a registry or an index.
Abstract
Intestinal dysbiosis is thought to be an important cause of disease progression and the gastrointestinal symptoms experienced in patients with inflammatory bowel disease (IBD). Inflammation appears to be a major contributor in perpetuating a dysregulated gut microbiota. Although current drug therapies can significantly induce and maintain disease remission, there is no cure for these diseases. Nevertheless, ongoing human studies investigating dietary fibre interventions may potentially prove to exert beneficial outcomes for IBD. Postulated mechanisms include direct interactions with the gut mucosa through immunomodulation, or indirectly through the microbiome. Component species of the microbiome may degrade dietary-fibre polysaccharides and ferment the products to form short-chain fatty acids such as butyrate. Prebiotic dietary fibres may also act more directly by altering the composition of the microbiome. Longer term benefits in reducing the risk of more aggressive disease or colorectal cancer may require other dietary fibre sources such as wheat bran or psyllium. By critically examining clinical trials that have used dietary fibre supplements or dietary patterns containing specific types or amounts of dietary fibres, it may be possible to assess whether varying the intake of specific dietary fibres may offer an efficient treatment for IBD patients.
Overview
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
Citations
Cites
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,667 · cited 1×
“Various prebiotic DFs have been found to have this activity [95].”
BackgroundHost–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 1×
“Besides the role of genetic predisposition in the development of IBD [9], diet”
BackgroundSelf-citationSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 2×
“prausnitzii has been correlated to protecting patients from IBD and a higher proportion of this bacterium in the gut microbiota tends to associate with disease remission [92,93].”
Background(1992) · PubMed · Cited by 3,809
Evolution of mammals and their gut microbes
Ley, R. E., Hamady, M., Lozupone, C., Turnbaugh, P. J., Ramey, R. R., Bircher, J. S., Schlegel, M. L., Tucker, T. A., Schrenzel, M. D., Knight, R., et al. (2008) · Science · doi:10.1126/science.1155725 · Cited by 3,747
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi-Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,553 · cited 1×
“Certain bacterial species, including Bifidobacteria and Faecalibacterium prausnitzii, have been shown to cause immunoregulatory effects following activation of dendritic cells that recognise bacteria in the intestinal microbiota, using pattern recognition receptors such as toll-like receptors (TLRs) that bind to disti…”
BackgroundInflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920 · cited 1×
“Furthermore, IBD complications that can arise are an obstructed bowel and the passing of mucus, pus or blood [6,7].”
BackgroundIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 1×
“Another difference observed in patients with intestinal inflammation compared with healthy individuals is an impaired intestinal barrier thought to be controlled by diet and bacterial species residing in the gut microbiota [94].”
BackgroundDysbiosis of the gut microbiota in disease
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26191 · Cited by 1,710 · cited 1×
“As well as modulating inflammation, there is also evidence that intestinal dysbiosis is involved with the development of colorectal cancer in IBD patients [62].”
BackgroundPotential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Research works printed but not linked: 4
- Watson, R., Preedy, V., and Zibadi, S. (2014). Wheat and Rice in Disease Prevention and Health: Benefits, Risks, and Mechanisms of Whole Grains in Health Promotion, Academic Press.
- Singh, J., and Kaur, L. (2009). Advances in Potato Chemistry and Technology, Academic Press.
- Ralph, J., Brunow, G., and Boerjan, W. (2007). Encyclopedia of Life Sciences, John Wiley & Sons.
- Harris, P.J., and Fincher, G.B. (2009). Chemisty, Biochemistry, and Biology of the (1,3)-β-d-Glucans and Related Polysaccharides, Academic Press.
Cited by
The Health Benefits of Dietary Fibre
Barber, T. M., Kabisch, S., Pfeiffer, A. F. H., & Weickert, M. O. (2020) · Nutrients · doi:10.3390/nu12103209 · Cited by 892
“Signalling pathways that implicate nuclear factor kappa-B (NF-kB) and inhibition of deacetylase influence inflammatory processes both locally (including gut-wall leakiness and colonic inflammation in patients with inflammatory bowel disease [68]) and systemically, and both are likely influenced by levels of butyrate w…”
BackgroundDiet as a Trigger or Therapy for Inflammatory Bowel Diseases
Lewis, J. D., & Abreu, M. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.019 · Cited by 375
Roy, S., & Dhaneshwar, S. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i14.2078 · Cited by 334
Niu, W., Chen, X., Xu, R., Dong, H., Yang, F., Wang, Y., Zhang, Z., & Ju, J. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117189 · Cited by 237
Korcz, E., Kerényi, Z., & Varga, L. (2018) · Food & Function · doi:10.1039/c8fo00118a · Cited by 222
Metadata
- Authors
- Wong, C., Harris, P., & Ferguson, L.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Ferguson, Lynnette
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2016-06-14
- Volume
- 17
- Issue
- 6
- Pages
- 919
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC4926452
- OpenAlex
- W2438382511
- Cited by
- 116
- References
- 110
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 6 · 2023: 11 · 2022: 26 · 2021: 12 · 2020: 19 · 2019: 7 · 2018: 14 · 2017: 6 · 2016: 2
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ResearchSpace (University of Auckland) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Keywords
- dietary fiber, inflammatory bowel disease, gut dysbiosis, gut microbiota, short-chain fatty acids, butyrate, prebiotics, immunomodulation, wheat bran, psyllium, colorectal cancer risk
- MeSH terms
- Dietary Fiber, Humans, Psyllium, Inflammatory Bowel Diseases, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease. https://app.cochat.ai/papers/10.3390/ijms17060919
- The paper
- Wong, C., Harris, P., & Ferguson, L. (2016). Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms17060919
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
